<DOC>
	<DOCNO>NCT01044316</DOCNO>
	<brief_summary>This study evaluate safety efficacy two dos two commercially available vaccine use prevent Haemophilus influenzae type b infection child 6-12 month age .</brief_summary>
	<brief_title>Study Infants ( 6-12 Months ) Comparing Two Doses Monovalent Glycoprotein-Conjugated ( Diptheria Toxin -CRM197 ) Vaccine Versus Tetanus Toxoid-Conjugated Vaccine Available Prevention Haemophilus Influenzae Type b Infections China</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Infants 612 month age . Prior Hib vaccine administration . History serious reaction ( ) follow vaccination . Any vaccination within 14 day study vaccination . Known suspected immune impairment . For additional entry criterion please refer protocol .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Haemophilus influenzae type b ( Hib )</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Booster</keyword>
</DOC>